Search

everythinglearnresearchcommunity

for

Search:↓

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Continuous baricitinib is needed to keep hair regrowth in severe alopecia areata.

Many women experience sexual dysfunction, but few seek help, and better treatment and medical training are needed.

Men with early balding should be checked for metabolic syndrome, as there's a link between the two.

Researchers discovered potential origins and new treatments for skin cancer, including biomarkers for melanoma and therapies that reduce tumor growth.

Hair loss treated with minoxidil, finasteride, laser/light, hair transplant, and scalp prostheses; more research needed for skin of color.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

Microneedles help improve skin appearance and deliver skin treatments effectively, but safety concerns need more research and regulation.

New targets for making and using brain-synthesized steroids could lead to better treatments for brain disorders and alcoholism.

The document concludes that diagnosing and treating Human African Trypanosomiasis is challenging, but new treatments like fexinidazole are promising.

Acne treatment varies, with topical and systemic therapies effective, and more research needed on treatment order and long-term effects.

Topical JAK inhibitors may help treat some skin conditions but need more research.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

The document concludes that sexual and psychiatric side effects from 5-alpha-reductase inhibitors are reported, but more high-quality research is needed to understand how often they occur.

Trichoscan is a reliable method for measuring hair growth and monitoring treatment effectiveness in hair loss.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

Hormonal treatments can improve acne, but they come with potential side effects and risks.

The document concludes that certain mutations may contribute to the inflammation in hidradenitis suppurativa and suggests that targeting TNFα could be a treatment strategy.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Men prefer less invasive cosmetic procedures and need different treatment approaches than women.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Adding stem cells to fat grafts for facial rejuvenation might improve outcomes, but more research is needed to confirm safety and effectiveness.